Issue No. 02 · 2026

Lipofilling in
Breast Reconstruction

Systematic review | Muntean et al., Journal of Clinical Medicine, 2025 · Systematic evidence on safety, aesthetic outcomes, and implications for LipAge Fill
Executive Summary

Muntean et al. (2025) conducted a systematic review of 16 clinical studies — 730 patients — evaluating hybrid breast reconstruction (HBR): a prosthetic implant combined with autologous lipofilling.

① Overall complication rate: 9% — lower than IBR in comparative studies. ② Immediate lipofilling showed a lower complication rate (8%) than delayed lipofilling (12%). ③ Mean aesthetic satisfaction: 4.4/5. ④ Oncological safety: zero recurrences reported in the included studies.

For LipAge: this study supports plastic surgeons who perform mastectomies and reconstructions as a high-value target audience — and shows that preserved autologous fat has a documented clinical application in this very setting.

730
patients (16 studies)
9%
overall complication rate
4.4/5
mean aesthetic satisfaction
0
oncological recurrences
01

Background — Why Lipofilling Became Part of Breast Reconstruction

Implant-based breast reconstruction (IBR) is currently the most widely used approach after mastectomy. However, its limitations are well known: capsular contracture, upper-pole rippling, compromised skin quality in patients who have undergone irradiation, and dissatisfaction with how natural the result looks.

Autologous lipofilling was introduced to address these limitations. Autologous fat acts through two complementary mechanisms: immediate volume restoration and tissue remodeling mediated by the paracrine effects of the stromal vascular fraction (SVF) — including neoangiogenesis, immunomodulation, and improved skin quality.

02

Lipofilling Timing — A Clinically Actionable Finding

⏱ Immediate vs. Delayed Lipofilling — Timing Matters

Patel et al. (included in the review) directly compared the groups:

• Immediate lipofilling (at the time of implant placement): complication rate of 8% — fewer additional surgeries — reconstruction completed more than 1 year earlier (p < 0.001)

• Delayed lipofilling (a separate procedure): complication rate of 12% — more interventions — longer recovery

Direct implication for LipAge: surgeons who cryopreserve fat at the time of initial collection have high-quality autologous material available for future use upon medical indication — including revision or refinement procedures, without the need for another collection.

03

Aesthetic Outcomes — What Fat Can Do That an Implant Cannot

  • Improved skin quality: increased elasticity and hydration of the skin over the implant (Serra-Renom et al.; Razzouk et al.)
  • Thickening of the skin envelope: formation of thicker subcutaneous tissue — reduced rippling (Sommeling et al.)
  • Less need for larger implants: fat grafting (FG) allows smaller implants to be used with equal or better results
  • Reduced post-mastectomy pain: FG associated with a reduction in post-mastectomy pain syndrome (Cogliandro et al.; Caviggioli et al.)
  • Patient satisfaction (BREAST-Q): significant improvement in satisfaction scores in studies using the validated questionnaire
04

Oncological Safety

🔬 Key Finding of the Review

No oncological recurrence was reported in the 16 included studies (730 patients, mean follow-up of 20.23 months).

Additional support: Kuruvilla et al. (Ann Plast Surg, 2023) — no increase in recurrence after FG in breast conservation. Tukiama et al. (Eur J Surg Oncol, 2022) — FG in post-mastectomy reconstruction with no adverse oncological impact.

⚠ Important Limitation

The mean follow-up of 20 months is a genuine limitation — late recurrences (>5 years) are not covered by the available data. Long-term oncological follow-up remains mandatory.

05

What Can and Cannot Be Said to Partner Physicians

✅A systematic review involving 730 patients (J. Clin. Med. 2025) documents that autologous lipofilling combined with implant-based reconstruction has an overall complication rate of 9%, mean aesthetic satisfaction of 4.4/5, and no oncological recurrence in the included studies.
✅LipAge cryopreserves autologous fat with certified QA/QC, making it available for future use upon medical indication — including reconstruction and refinement procedures.
❌That LipAge ensures the same outcomes as the reviewed studies, or that cryopreservation does not affect graft quality compared with immediate use — direct comparative data do not yet exist.
❌Definitive long-term oncological safety — existing data cover a mean follow-up of 20 months.

Reviewed Article Details

TitleExploring the Role of Autologous Fat Grafting in Implant-Based Breast Reconstruction: A Systematic Review
AuthorsMuntean MV, Pop IC, Ilies RA et al.
JournalJournal of Clinical Medicine (MDPI)
Year2025 — DOI: 10.3390/jcm14124073
TypePRISMA systematic review; PubMed + Embase search
N730 patients; 16 studies; mean follow-up of 20.23 months
Relevance to LipAgeHigh — validates autologous fat in implant-based reconstructive surgery, confirms medium-term oncological safety